Valneva has announced that the European Medicines Agency has accepted its marketing authorization application for its single-dose chikungunya vaccine candidate VLA1553.The chikungunya virus, or.
Valneva Reports Positive Pivotal Phase 3 Immunogenicity Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Valneva Announces U S FDA Approval of World s First Chikungunya Vaccine, IXCHIQ® | 10 11 23 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
FDA signs off on Valneva s chikungunya vaccine Ixchiq fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.